PYC THERAPEUTICS LIMITEDPYC THERAPEUTICS LIMITEDPYC THERAPEUTICS LIMITED

PYC THERAPEUTICS LIMITED

No trades
See on Supercharts

PYC fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

PYC Therapeutics Ltd. is a drug-development company, which provides a new generation of RNA therapeutics to meet unmet need in disease. It develops intracellular biological therapeutics including its own preclinical oncology payloads, using its proprietary cell Functional Penetrating Phylomers. The company was founded by Richmond Miles Hopkins and Paul Michael Watt on October 9, 2001, and is headquartered in Nedlands, Australia.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
PYC has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company